Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Gains from Investment Securities (2017 - 2020)

enVVeno Medical has reported Gains from Investment Securities over the past 4 years, most recently at $210.7 million for Q4 2020.

  • For Q4 2020, Gains from Investment Securities rose 211246.29% year-over-year to $210.7 million; the TTM value through Dec 2020 reached $210.7 million, up 211246.29%, while the annual FY2020 figure was $210.7 million, 211246.29% up from the prior year.
  • Gains from Investment Securities for Q4 2020 was $210.7 million at enVVeno Medical, up from $99689.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $210.7 million in Q4 2020 and troughed at -$14649.0 in Q3 2018.
  • A 4-year average of $30.4 million and a median of $111829.0 in 2018 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 96.16% in 2019 and later skyrocketed 211246.29% in 2020.
  • Year by year, Gains from Investment Securities stood at $1.4 million in 2017, then tumbled by 92.14% to $111829.0 in 2018, then dropped by 10.86% to $99689.0 in 2019, then skyrocketed by 211246.29% to $210.7 million in 2020.
  • Business Quant data shows Gains from Investment Securities for NVNO at $210.7 million in Q4 2020, $99689.0 in Q4 2019, and $6137.0 in Q2 2019.